Basel Area Life Sciences Supercluster

The Basel Area Life Sciences Supercluster is Europe’s most
concentrated destination for biotech, pharma, healthtech
and medtech innovation.

[Basel Area Life Sciences Supercluster @BaselArea]

BIIE aims to connect immune engineering research in the Basel Area with clinical partners around the world. In an interview with @BioPharmInt, Stephen Wilson, CEO of BIIE, shares how his institute plans to leverage the Basel Area to build global partnerships and advance its mission #supercluster #biotech
https://t.co/OGg9mkH0V1

[Basel Area Life Sciences Supercluster @BaselArea]

How the right environment accelerates #biotech innovation. Our CEO Christof Klöpper explains @DDWJournal how ecoystems for biotech can advance innovation and why the Basel Area is an example of an impressive concentration of talent.
https://t.co/aEPYnTrPB7

[Basel Area Life Sciences Supercluster @BaselArea]

Our CEO Christof Klöpper shares @BiotechTV the history of life sciences in Basel and describes the investments in infrastructure that have been made over recent years #supercluster #biotech
https://t.co/tryK5nUNj8

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Christof Kloepper, CEO of Basel Area Business & Innovation, shares the history of life sciences in Basel and describes the investments in infrastructure that have been made over recent years.

Full video: https://t.co/8b0A36pdmU

[Basel Area Life Sciences Supercluster @BaselArea]

How can different technologies come together to advance immune engineering? In @BioPharmIntl, Stephen Wilson, CEO of BIIE, explains how the institute is building an integrated technology stack within the Basel Area #supercluster #biotech
https://t.co/PiR3C4SrtN

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Kicking off @ByAmyBrown's tour of Switzerland this week - today from Basel. Thanks to @BaselArea for making it possible.

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: With two products on the market with momentum and a key pipeline asset in a P3, Basilea has become a world leader in the development of therapies for bacterial and fungal infections.

Full video: https://t.co/j6Z9kCCBsV

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: @BaseLaunch is designed to help early stage companies with resources that they might not have access to on their own.

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Synendos Therapeutics is targeting the the endocannabinod system of the brain to restore balance and treat CNS conditions.

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐁𝐚𝐬𝐞𝐥: Forty51 Ventures was formed in Basel four years ago and has a company building model - they look globally, but believe that having the pharma company pipeline in Basel is an advantage. @baselarea

Full video: https://t.co/2PKRYisLkw

[Basel Area Life Sciences Supercluster @BaselArea]

Strong signal of the science moving from lab to launch in the Basel Area 🧬 Six life sciences startups from the Basel Area made the TOP 100 Swiss Startup Awards 2026 - with Aukera Therapeutics ranked the #1 biotech startup. Also named among  the TOP 100: NXI Therapeutics, Mosanna Therapeutics, FimmCyte, Engimmune Therapeutics, @bottneuro #supercluster #biotech
https://t.co/lBju55hR8v

[BioPharm Intl @BioPharmIntl]

Translational research is driving progress in immune engineering as collaboration grows across academia and industry with @BaselArea. Hear insights from Dr Stephen Wilson, CEO, BIIE: https://t.co/fiwHhoawqc

#ImmuneEngineering #TranslationalResearch

[Basel Area Life Sciences Supercluster @BaselArea]

How can an innovation ecosystem support a new immune engineering research institute? Stephen Wilson, CEO of BIIE, explains in @BioPharmIntl why the institute chose Basel for its new research facility. Basel’s concentrated ecosystem connects highly qualified local professionals with international scientists, universities, and global pharma. #supercluster #biotech
https://t.co/ZAm6pifWBf

[Basel Area Life Sciences Supercluster @BaselArea]

Why should emerging biopharmaceutical companies consider market access and commercial factors earlier? How can the Basel Area’s concentration of cross-functional talent enhance product development and launch? In an interview with @BioPharmIntl, @khdetrick shares insights. #supercluster #biotech
https://t.co/MpRUaAK5Z5

[Basel Area Life Sciences Supercluster @BaselArea]

How does the Basel Area’s infrastructure help biopharma companies scale? In an interview with @BioPharmIntl, Senn Development CEO Johannes Eisenhut explores how flexible lab space, GMP-ready facilities, and academia-industry collaboration at the Main Campus of the @swissinnova Park Basel Area support companies from early-stage research to manufacturing scale-up. #Supercluster #LifeSciences
https://t.co/VDPGrO4Gek

[Basel Area Life Sciences Supercluster @BaselArea]

Commercializing independently in Europe is becoming a real strategic option for emerging biotechs. Choosing the right ecosystem is part of the commercialization strategy. As @khdetrick writes @pharmaphorum: In the Basel Area, commercial talent and expertise across the launch journey are already within reach. #supercluster #biotech
https://t.co/KoVjnWXMVW

[Basel Area Life Sciences Supercluster @BaselArea]

Choosing the right lab location is increasingly about access to expertise and talent, strong networks for collaboration, and specialized laboratory infrastructure. @labdesignnews highlights the Basel Area as one of the world’s leading locations where companies can find all of this in one place. #supercluster #biotech
https://t.co/w77j3onhip